Kevin Lee Freeman - Net Worth and Insider Trading

Kevin Lee Freeman Net Worth

The estimated net worth of Kevin Lee Freeman is at least $1 Million dollars as of 2025-04-02. Kevin Lee Freeman is the Chief Commercial Officer of Health Catalyst Inc and owns about 236,950 shares of Health Catalyst Inc (HCAT) stock worth over $1 Million. Details can be seen in Kevin Lee Freeman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Lee Freeman has not made any transactions after 2024-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Kevin Lee Freeman

To

Kevin Lee Freeman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin Lee Freeman owns 1 companies in total, including Health Catalyst Inc (HCAT) .

Click here to see the complete history of Kevin Lee Freeman’s form 4 insider trades.

Insider Ownership Summary of Kevin Lee Freeman

Ticker Comapny Transaction Date Type of Owner
HCAT Health Catalyst Inc 2024-12-02 Chief Growth Officer

Kevin Lee Freeman Latest Holdings Summary

Kevin Lee Freeman currently owns a total of 1 stock. Kevin Lee Freeman owns 236,950 shares of Health Catalyst Inc (HCAT) as of December 2, 2024, with a value of $1 Million.

Latest Holdings of Kevin Lee Freeman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HCAT Health Catalyst Inc 2024-12-02 236,950 4.33 1,025,994

Holding Weightings of Kevin Lee Freeman


Kevin Lee Freeman Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin Lee Freeman has made a total of 3 transactions in Health Catalyst Inc (HCAT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Health Catalyst Inc is the sale of 7,500 shares on December 2, 2024, which brought Kevin Lee Freeman around $67,050.

Insider Trading History of Kevin Lee Freeman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin Lee Freeman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kevin Lee Freeman Ownership Network

Ownership Network List of Kevin Lee Freeman

No Data

Ownership Network Relation of Kevin Lee Freeman

Insider Network Chart

Kevin Lee Freeman Owned Company Details

What does Health Catalyst Inc do?

Who are the key executives at Health Catalyst Inc?

Kevin Lee Freeman is the Chief Growth Officer of Health Catalyst Inc. Other key executives at Health Catalyst Inc include General Counsel Benjamin Landry , Chief People Officer Linda Llewelyn , and Chief Accounting Officer Jason Alger .

Health Catalyst Inc (HCAT) Insider Trades Summary

Over the past 18 months, Kevin Lee Freeman made 3 insider transaction in Health Catalyst Inc (HCAT) with a net sale of 22,500. Other recent insider transactions involving Health Catalyst Inc (HCAT) include a net sale of 42,005 shares made by Linda Llewelyn , a net sale of 90,988 shares made by , and a net sale of 53,025 shares made by Benjamin Landry .

In summary, during the past 3 months, insiders sold 56,530 shares of Health Catalyst Inc (HCAT) in total and bought 0 shares, with a net sale of 56,530 shares. During the past 18 months, 245,016 shares of Health Catalyst Inc (HCAT) were sold and 26,200 shares were bought by its insiders, resulting in a net sale of 218,816 shares.

Health Catalyst Inc (HCAT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Health Catalyst Inc Insider Transactions

No Available Data

Kevin Lee Freeman Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin Lee Freeman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Kevin Lee Freeman's mailing address is: South Jordan Ut 84095.